Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children?

Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Meth...

Full description

Saved in:
Bibliographic Details
Published inPediatric pulmonology Vol. 58; no. 11; pp. 3303 - 3313
Main Authors Aoust, Laura, Berteloot, Laureline, Drabent, Philippe, Garcelon, Nicolas, Bodemer, Christine, Molina, Thierry Jo, Bader‐Meunier, Brigitte, Hadchouel, Alice
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc 01.11.2023
Wiley
Subjects
Online AccessGet full text
ISSN8755-6863
1099-0496
1099-0496
DOI10.1002/ppul.26660

Cover

Loading…
Abstract Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Methods We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Results Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07). Conclusion We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
AbstractList Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.INTRODUCTIONInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.METHODSWe retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD-ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD-ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD-ILD group, p = .07).RESULTSAmong 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD-ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD-ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD-ILD group, p = .07).We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD-ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.CONCLUSIONWe confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD-ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
IntroductionInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.MethodsWe retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.ResultsAmong 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07).ConclusionWe confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Methods We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Results Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07). Conclusion We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
Abstract Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Methods We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Results Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07). Conclusion We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
Author Hadchouel, Alice
Berteloot, Laureline
Aoust, Laura
Garcelon, Nicolas
Bodemer, Christine
Bader‐Meunier, Brigitte
Molina, Thierry Jo
Drabent, Philippe
Author_xml – sequence: 1
  givenname: Laura
  surname: Aoust
  fullname: Aoust, Laura
  organization: AP‐HP, Hôpital Universitaire Necker‐Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de l'Enfant
– sequence: 2
  givenname: Laureline
  surname: Berteloot
  fullname: Berteloot, Laureline
  organization: AP‐HP, Service d'Imagerie Pédiatrique, Hôpital Universitaire Necker‐Enfants Malades
– sequence: 3
  givenname: Philippe
  surname: Drabent
  fullname: Drabent, Philippe
  organization: AP‐HP, Hôpitaux Universitaires Necker‐Enfants Malades et Robert Debré, Service d'Anatomie Pathologique
– sequence: 4
  givenname: Nicolas
  surname: Garcelon
  fullname: Garcelon, Nicolas
  organization: Université de Paris
– sequence: 5
  givenname: Christine
  surname: Bodemer
  fullname: Bodemer, Christine
  organization: Université Paris Cité
– sequence: 6
  givenname: Thierry Jo
  surname: Molina
  fullname: Molina, Thierry Jo
  organization: Université Paris Cité
– sequence: 7
  givenname: Brigitte
  surname: Bader‐Meunier
  fullname: Bader‐Meunier, Brigitte
  organization: Imagine Institute, INSERM U1163, Paris Cité University
– sequence: 8
  givenname: Alice
  orcidid: 0000-0001-7451-9890
  surname: Hadchouel
  fullname: Hadchouel, Alice
  email: alice.hadchouel-duverge@aphp.fr
  organization: INSERM U1151, Institut Necker Enfants Malades
BackLink https://inria.hal.science/hal-04339467$$DView record in HAL
BookMark eNp90ctqGzEUBmARUqiTZtMnGOimLUyq2-jSTTGhuYAhXthrodFIjYKscSVNgt--cidkEUpXAun7Dzr8Z-A0jtEC8BHBSwQh_rbfT-ESM8bgCVggKGULqWSnYCF417VMMPIenOX8CGF9k2gBNttogs7ZO6_7YBsfi025-OJ1aMIUfzWDz1Zn2-g4NHoqo9_tpujL4XuzGZ91GnJzt15e12BjHnwYko0_PoB3TodsL17Oc7C9_rm5um1X9zd3V8tVayiksKXSCSkNl53FHHecm97qTguJuLGDcIwgaSnpXUfqbq7HDlJLBWSO9D3FPTkHX-a5DzqoffI7nQ5q1F7dLlfqeAcpIZIy_oSq_TzbfRp_TzYXtfPZ2BB0tOOUFRaMMsSk4JV-ekMfxynFuklVXEiOCYZVfZ2VSWPOybrXHyCojmWoYxnqbxkVwzfY-KKLH2NJ2od_R9AcefbBHv4zXK3X29Wc-QP0vZ2V
CitedBy_id crossref_primary_10_1002_ppul_27108
crossref_primary_10_3389_fped_2023_1307607
Cites_doi 10.1016/j.jbi.2018.02.019
10.1016/j.rmed.2018.02.024
10.1016/j.semarthrit.2022.152088
10.1007/s10067-018-4111-5
10.1378/chest.10-2662
10.1080/02841850902787677
10.1186/s13023-019-1270-7
10.1007/s10067-019-04836-3
10.1111/resp.13665
10.1513/AnnalsATS.201501-064OC
10.1016/j.ejim.2021.12.021
10.1016/j.rmed.2019.03.011
10.1080/03009742.2021.1907945
10.1016/j.rmed.2016.09.002
10.1016/j.rmed.2016.10.017
10.1016/j.chest.2017.03.004
10.1016/j.autrev.2019.102451
10.1002/ppul.1950160309
10.1183/13993003.00150-2015
10.2214/AJR.18.20696
10.2214/ajr.170.3.9490955
10.1097/RHU.0000000000001847
10.1002/ppul.23178
10.1186/s12890-019-0868-9
10.1183/13993003.01565-2015
10.1016/j.rmed.2021.106566
10.1183/16000617.0177-2021
10.1164/rccm.200703-393OC
10.1111/resp.13254
10.1097/MD.0000000000018589
10.1002/ppul.22742
10.1186/s12890-017-0453-z
10.1056/NEJMoa1908681
10.3389/fmed.2019.00209
10.1089/ped.2010.0008
10.1164/rccm.201305-0923ST
10.1159/000515396
ContentType Journal Article
Copyright 2023 The Authors. published by Wiley Periodicals LLC.
2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 Wiley Periodicals LLC.
Attribution
Copyright_xml – notice: 2023 The Authors. published by Wiley Periodicals LLC.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 Wiley Periodicals LLC.
– notice: Attribution
DBID 24P
AAYXX
CITATION
K9.
7X8
1XC
DOI 10.1002/ppul.26660
DatabaseName Wiley Online Library Open Access
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)


Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1099-0496
EndPage 3313
ExternalDocumentID oai_HAL_hal_04339467v1
10_1002_ppul_26660
PPUL26660
Genre article
GrantInformation_xml – fundername: None
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
K9.
7X8
1XC
ID FETCH-LOGICAL-c4040-49f899c795e272577cbea5a8917ced8f6319e43bf53002fb2f04e4806f3bb42b3
IEDL.DBID 24P
ISSN 8755-6863
1099-0496
IngestDate Fri May 09 12:25:29 EDT 2025
Fri Jul 11 03:42:02 EDT 2025
Fri Jul 25 21:50:22 EDT 2025
Tue Jul 01 05:28:03 EDT 2025
Thu Apr 24 23:13:06 EDT 2025
Sun Jul 06 04:46:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License Attribution-NonCommercial-NoDerivs
Attribution: http://creativecommons.org/licenses/by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4040-49f899c795e272577cbea5a8917ced8f6319e43bf53002fb2f04e4806f3bb42b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7451-9890
0000-0002-3326-2811
0000-0001-8772-0905
0000-0001-8476-8196
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26660
PQID 2878972320
PQPubID 1036356
PageCount 0
ParticipantIDs hal_primary_oai_HAL_hal_04339467v1
proquest_miscellaneous_2864616987
proquest_journals_2878972320
crossref_primary_10_1002_ppul_26660
crossref_citationtrail_10_1002_ppul_26660
wiley_primary_10_1002_ppul_26660_PPUL26660
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2023
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Pediatric pulmonology
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Wiley
Publisher_xml – name: Wiley Subscription Services, Inc
– name: Wiley
References 2015; 12
2013; 48
2019; 6
2015; 50
2022; 51
2020; 39
2013; 188
2018; 80
2019; 19
2020; 15
2017; 152
2021; 100
2020; 99
2021; 187
2018; 23
2021; 30
2019; 381
2022; 28
2020; 19
2015; 46
2010; 23
1998; 170
1993; 16
2016; 119
2017; 17
2009; 50
2007; 176
2018; 137
2022; 57
2019; 212
2020; 25
2022; 97
2017; 123
2011; 140
2019; 150
2016; 47
2018; 37
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_22_1
e_1_2_10_20_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_31_1
e_1_2_10_30_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 17
  issue: 1
  year: 2017
  article-title: Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features
  publication-title: BMC Pulm Med
– volume: 23
  start-page: 33
  issue: 1
  year: 2010
  end-page: 41
  article-title: Interstitial lung disease in children older than 2 years
  publication-title: Pediatr Allergy Immunol Pulmonol
– volume: 37
  start-page: 2125
  issue: 8
  year: 2018
  end-page: 2132
  article-title: Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population‐based study
  publication-title: Clin Rheumatol
– volume: 19
  issue: 2
  year: 2020
  article-title: Interstitial pneumonia with autoimmune features: a single center prospective follow‐up study
  publication-title: Autoimmun Rev
– volume: 187
  year: 2021
  article-title: Clinical spectrum of children with interstitial pneumonia with autoimmune features
  publication-title: Respir Med
– volume: 15
  year: 2020
  article-title: Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age
  publication-title: Orphanet J Rare Dis
– volume: 51
  start-page: 34
  issue: 1
  year: 2022
  end-page: 41
  article-title: Rheumatological evaluation of patients with interstitial lung disease
  publication-title: Scand J Rheumatol
– volume: 100
  start-page: 853
  issue: 9
  year: 2021
  end-page: 864
  article-title: Baseline characteristics and survival of an Australian interstitial pneumonia with autoimmune features cohort
  publication-title: Respiration
– volume: 28
  start-page: 257
  issue: 5
  year: 2022
  end-page: 264
  article-title: Identification and prognosis of patients with interstitial pneumonia with autoimmune features
  publication-title: J Clin Rheumatol
– volume: 25
  start-page: 636
  issue: 6
  year: 2020
  end-page: 643
  article-title: Long‐term clinical course and outcome of interstitial pneumonia with autoimmune features
  publication-title: Respirology
– volume: 46
  start-page: 976
  issue: 4
  year: 2015
  end-page: 987
  article-title: An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
  publication-title: Eur Respir J
– volume: 123
  start-page: 56
  year: 2017
  end-page: 62
  article-title: Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients
  publication-title: Respir Med
– volume: 50
  start-page: 1159
  issue: 12
  year: 2015
  end-page: 1169
  article-title: Sex and the lung: observations, hypotheses, and future directions: sex and the lung
  publication-title: Pediatr Pulmonol
– volume: 57
  year: 2022
  article-title: The role of myositis‐specific autoantibodies and the management of interstitial lung disease in idiopathic inflammatory myopathies: a systematic review
  publication-title: Semin Arthritis Rheum
– volume: 188
  start-page: 376
  issue: 3
  year: 2013
  end-page: 394
  article-title: An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy
  publication-title: Am J Respir Crit Care Med
– volume: 119
  start-page: 150
  year: 2016
  end-page: 154
  article-title: Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience
  publication-title: Respir Med
– volume: 16
  start-page: 184
  issue: 3
  year: 1993
  end-page: 196
  article-title: Chronic interstitial lung disease in children
  publication-title: Pediatr Pulmonol
– volume: 19
  issue: 1
  year: 2019
  article-title: Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
  publication-title: BMC Pulm Med
– volume: 152
  start-page: 103
  issue: 1
  year: 2017
  end-page: 112
  article-title: Idiopathic interstitial pneumonia associated with autoantibodies
  publication-title: Chest
– volume: 99
  issue: 4
  year: 2020
  article-title: Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases
  publication-title: Medicine
– volume: 39
  start-page: 575
  issue: 2
  year: 2020
  end-page: 583
  article-title: Comparative analysis of connective tissue disease‐associated interstitial lung disease and interstitial pneumonia with autoimmune features
  publication-title: Clin Rheumatol
– volume: 381
  start-page: 1718
  issue: 18
  year: 2019
  end-page: 1727
  article-title: Nintedanib in progressive fibrosing interstitial lung diseases
  publication-title: N Engl J Med
– volume: 140
  start-page: 1292
  issue: 5
  year: 2011
  end-page: 1299
  article-title: Autoimmune‐featured interstitial lung disease
  publication-title: Chest
– volume: 48
  start-page: 1016
  issue: 10
  year: 2013
  end-page: 1025
  article-title: The lung is involved in juvenile dermatomyositis
  publication-title: Pediatr Pulmonol
– volume: 212
  start-page: 1
  year: 2019
  end-page: 10
  article-title: Childhood interstitial (Diffuse) lung disease: pattern recognition approach to diagnosis in infants
  publication-title: Am J Roentgenol
– volume: 6
  year: 2019
  article-title: Interstitial pneumonia with autoimmune features (IPAF)
  publication-title: Front Med
– volume: 170
  start-page: 691
  issue: 3
  year: 1998
  end-page: 697
  article-title: Systemic sclerosis: using high‐resolution CT to detect lung disease in children
  publication-title: Am J Roentgenol
– volume: 80
  start-page: 52
  year: 2018
  end-page: 63
  article-title: A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse
  publication-title: J Biomed Inf
– volume: 50
  start-page: 430
  issue: 4
  year: 2009
  end-page: 436
  article-title: Chest abnormalities in juvenile‐onset mixed connective tissue disease: assessment with high‐resolution computed tomography and pulmonary function tests
  publication-title: Acta Radiol
– volume: 23
  start-page: 600
  issue: 6
  year: 2018
  end-page: 605
  article-title: Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality
  publication-title: Respirology
– volume: 150
  start-page: 154
  year: 2019
  end-page: 160
  article-title: Clinical, serological and radiological features of a prospective cohort of interstitial pneumonia with autoimmune features (IPAF) patients
  publication-title: Respir Med
– volume: 12
  start-page: 1498
  issue: 10
  year: 2015
  end-page: 1505
  article-title: Diffuse lung disease in biopsied children 2 to 18 years of age. application of the chILD classification scheme
  publication-title: Ann Am Thorac Soc
– volume: 30
  issue: 162
  year: 2021
  article-title: Interstitial pneumonia with autoimmune features: challenges and controversies
  publication-title: Eur Respir Rev
– volume: 137
  start-page: 167
  year: 2018
  end-page: 175
  article-title: Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia
  publication-title: Respir Med
– volume: 47
  start-page: 1767
  issue: 6
  year: 2016
  end-page: 1775
  article-title: Characterisation of patients with interstitial pneumonia with autoimmune features
  publication-title: Eur Respir J
– volume: 176
  start-page: 1120
  issue: 11
  year: 2007
  end-page: 1128
  article-title: Diffuse lung disease in young children: application of a novel classification scheme
  publication-title: Am J Respir Crit Care Med
– volume: 97
  start-page: 62
  year: 2022
  end-page: 68
  article-title: Interstitial pneumonia with autoimmune features: evaluation of connective tissue disease incidence during follow‐up
  publication-title: Eur J Intern Med
– ident: e_1_2_10_26_1
  doi: 10.1016/j.jbi.2018.02.019
– ident: e_1_2_10_13_1
  doi: 10.1016/j.rmed.2018.02.024
– ident: e_1_2_10_38_1
  doi: 10.1016/j.semarthrit.2022.152088
– ident: e_1_2_10_12_1
  doi: 10.1007/s10067-018-4111-5
– ident: e_1_2_10_32_1
  doi: 10.1378/chest.10-2662
– ident: e_1_2_10_35_1
  doi: 10.1080/02841850902787677
– ident: e_1_2_10_24_1
  doi: 10.1186/s13023-019-1270-7
– ident: e_1_2_10_17_1
  doi: 10.1007/s10067-019-04836-3
– ident: e_1_2_10_20_1
  doi: 10.1111/resp.13665
– ident: e_1_2_10_5_1
  doi: 10.1513/AnnalsATS.201501-064OC
– ident: e_1_2_10_22_1
  doi: 10.1016/j.ejim.2021.12.021
– ident: e_1_2_10_16_1
  doi: 10.1016/j.rmed.2019.03.011
– ident: e_1_2_10_31_1
  doi: 10.1080/03009742.2021.1907945
– ident: e_1_2_10_9_1
  doi: 10.1016/j.rmed.2016.09.002
– ident: e_1_2_10_10_1
  doi: 10.1016/j.rmed.2016.10.017
– ident: e_1_2_10_19_1
  doi: 10.1016/j.chest.2017.03.004
– ident: e_1_2_10_21_1
  doi: 10.1016/j.autrev.2019.102451
– ident: e_1_2_10_27_1
  doi: 10.1002/ppul.1950160309
– ident: e_1_2_10_6_1
  doi: 10.1183/13993003.00150-2015
– ident: e_1_2_10_2_1
  doi: 10.2214/AJR.18.20696
– ident: e_1_2_10_37_1
  doi: 10.2214/ajr.170.3.9490955
– ident: e_1_2_10_18_1
  doi: 10.1097/RHU.0000000000001847
– ident: e_1_2_10_30_1
  doi: 10.1002/ppul.23178
– ident: e_1_2_10_15_1
  doi: 10.1186/s12890-019-0868-9
– ident: e_1_2_10_8_1
  doi: 10.1183/13993003.01565-2015
– ident: e_1_2_10_25_1
  doi: 10.1016/j.rmed.2021.106566
– ident: e_1_2_10_23_1
  doi: 10.1183/16000617.0177-2021
– ident: e_1_2_10_3_1
  doi: 10.1164/rccm.200703-393OC
– ident: e_1_2_10_14_1
  doi: 10.1111/resp.13254
– ident: e_1_2_10_33_1
  doi: 10.1097/MD.0000000000018589
– ident: e_1_2_10_34_1
  doi: 10.1002/ppul.22742
– ident: e_1_2_10_11_1
  doi: 10.1186/s12890-017-0453-z
– ident: e_1_2_10_28_1
  doi: 10.1056/NEJMoa1908681
– ident: e_1_2_10_29_1
  doi: 10.3389/fmed.2019.00209
– ident: e_1_2_10_36_1
  doi: 10.1089/ped.2010.0008
– ident: e_1_2_10_4_1
  doi: 10.1164/rccm.201305-0923ST
– ident: e_1_2_10_7_1
  doi: 10.1159/000515396
SSID ssj0009991
Score 2.4048703
Snippet Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do...
IntroductionInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not...
Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the...
Abstract Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity...
SourceID hal
proquest
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3303
SubjectTerms autoimmunity
children
connective tissue disease
Human health and pathology
intersitial lung disease
Life Sciences
Lung diseases
Title Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children?
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26660
https://www.proquest.com/docview/2878972320
https://www.proquest.com/docview/2864616987
https://inria.hal.science/hal-04339467
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rS8MwEA8-QPwiPnG-iI8vCtUtTdNGBBnqmKIyZAO_lSRLcDC64TbB_967tOsURPBLKe2ltJdcc5fL73eEnEjDjTWSBQqC5IA7IQLNVC3oKvCXVWxiV0Nw8tOzaHb4w2v0OkeupliYnB-iXHBDy_D_azRwpUcXM9LQ4XDSP4fpRUDAvojYWhzljLdmlLvS18sDhzwKRCLCkpyUXcza_piO5t9wM-Q3T_O7v-onnMYqWSk8RVrPu3aNzNlsnSw9FbnwDdLuZAZd357rIfyJIvHDO2b-YUTRPtgwLZIvVGVdqibjQc9jQcafl7TtN8uO6H2r3oCGdArpvt4kncZd-6YZFDUSAsNxMyCXDiImE8vIshjMLzbaqkglEIUZ202cABOzPNQuCuHDnWauyi1PqsKFWnOmwy2ykA0yu00oxHqSOSlixyMueFcnxlhcG2FRCJpyFXI6VVVqCgJxrGPRT3PqY5aiWlOv1go5LmWHOW3Gr1JHoPFSAJmum_XHFK8hr5qEn_hHrUL2ph2SFvY1SiHOS7BeGoNnHJa3wTIw3aEyO5igjOCiJmQSV8iZ78g_XiVttTqP_mznP8K7ZBnrz-fgxD2yMH6f2H3wUsb6wA9GON6-sC8ireJr
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dSyMxEA9-gN6LnF9Y9c748aKwarPZ7OZejiKWqq30oQXfQpImXKFsi7aC_70z2e1WQYR7W3Yny-4kk8znbwg5k5ZbZyWLNBjJEfdCRIbpejTQoC_r1Ka-jsXJnUfR6vP7p-SpzM3BWpgCH6JyuKFkhP0aBRwd0lcL1NDJZDa6hPNFgMW-ygVLsXMD490F5q4MDfNAI08ikYm4QidlV4uxn86j5X-YDflB1fyosIYTp_mTbJSqIm0Uc7tJlly-RdY6ZTB8m_T6uUXdd-iHWP9EEfnhGUP_sKToCISYltEXqvMB1bPpeBiKQaZvf2gvZMu-0LtuowkD6bym--8O6TdvezetqGySEFmO2YBcejCZbCoTx1KQv9QapxOdgRlm3SDzAmTM8dj4JIYf94b5a-54di18bAxnJt4lK_k4d3uEgrEnmZci9Tzhgg9MZq1D5whLYuCUr5HzOauULRHEsZHFSBXYx0whW1Vga42cVrSTAjfjS6oT4HhFgFDXrUZb4T0EVpOwi7_Wa-RwPiGqFLAXBYZehg3TGLzjuHoMooHxDp278QxpBBd1IbO0Ri7CRH7zKarb7bfD1f7_EB-R9Vav01btu8eHA_IDm9EXlYqHZGX6PHO_QGWZmt9hYb4DDIPk7g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-6DspeRvfFsrab9vGygddGlmVrDEbYFtItLX5IoG9CkiUaCE5ok0L_-97JjtPBGOzN2Cdjn3TS73S63wF8UE447xRPDDrJiQhSJpabflIZxMsmd3noU3Ly2bkcTcWvi-xiB75ucmEafohuw40sI87XZODLKhxvSUOXy_X8My4vEh32hxTto_HNRbml3FWxXh4C8iyRhUw7clJ-vG37x3L04JIOQ95DmvfxalxwhvvwuEWKbNB07RPY8fVT2DtrY-HPYDKtHUHfWZhR-hMj4ocrivzjiGJztGHWBl-YqStm1qvFLOaCrG6_sEk8LHvNTsvBEBuyTUr3t-cwHf6cfB8lbY2ExAk6DChUQI_J5SrzPEfzy531JjMFemHOV0WQaGJepDZkKf54sDycCC-KExlSawW36QvYrRe1fwkMfT3Fg5J5EJmQorKFc572RniWoqZCDz5uVKVdSyBOdSzmuqE-5prUqqNae_C-k102tBl_lXqHGu8EiOl6NBhruke8agon8Zt-Dw43HaJb-7rW6OcVVC-N4zvedo_RMijcYWq_WJOMFLIvVZH34FPsyH98ii7L6Thevfof4TewV_4Y6vHp-e8DeESl6Js8xUPYXV2t_REClpV9HcflHc0E5CA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unclassifiable+interstitial+lung+disease+and+autoimmunity%3A+Towards+IPAF+in+children%3F&rft.jtitle=Pediatric+pulmonology&rft.au=Aoust%2C+Laura&rft.au=Berteloot%2C+Laureline&rft.au=Drabent%2C+Philippe&rft.au=Garcelon%2C+Nicolas&rft.date=2023-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=8755-6863&rft.eissn=1099-0496&rft.volume=58&rft.issue=11&rft.spage=3303&rft.epage=3313&rft_id=info:doi/10.1002%2Fppul.26660&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8755-6863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8755-6863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8755-6863&client=summon